Baker McKenzie has advised Takeda. Skadden has advised Innovent Biologics. Takeda has entered into a global strategic partnership with Innovent Biologics, aimed at strengthening Takeda’s oncology...
Takeda Enters Global Strategic Partnership with Innovent Biologics for Oncology Pipeline Expansion
Share Placements by Innovent Biologics and Keymed Biosciences on HKEX Raise Over HK$5 Billion
Linklaters has advised the bookrunners on the share placings for Innovent Biologics, Inc. and Keymed Biosciences Inc. Skadden advised Innovent Biologics. Innovent Biologics, Inc. and Keymed...


























